GlaxoSmithKline CEO would consider dividing following the Novartis deal
Should GlaxoSmithKline split up into various smaller companies? Investor Neil Woodford thinks so.
Should GlaxoSmithKline split up into various smaller companies? Investor Neil Woodford thinks so.